A Bayesian model of acquisition and clearance of bacterial colonization
Authors:
Marko Järvenpää,
Mohamad R. Abdul Sater,
Georgia K. Lagoudas,
Paul C. Blainey,
Loren G. Miller,
James A. McKinnell,
Susan S. Huang,
Yonatan H. Grad,
Pekka Marttinen
Abstract:
Bacterial populations that colonize a host play important roles in host health, including serving as a reservoir that transmits to other hosts and from which invasive strains emerge, thus emphasizing the importance of understanding rates of acquisition and clearance of colonizing populations. Studies of colonization dynamics have been based on assessment of whether serial samples represent a singl…
▽ More
Bacterial populations that colonize a host play important roles in host health, including serving as a reservoir that transmits to other hosts and from which invasive strains emerge, thus emphasizing the importance of understanding rates of acquisition and clearance of colonizing populations. Studies of colonization dynamics have been based on assessment of whether serial samples represent a single population or distinct colonization events. A common solution to estimate acquisition and clearance rates is to use a fixed genetic distance threshold. However, this approach is often inadequate to account for the diversity of the underlying within-host evolving population, the time intervals between consecutive measurements, and the uncertainty in the estimated acquisition and clearance rates. Here, we summarize recently submitted work \cite{jarvenpaa2018named} and present a Bayesian model that provides probabilities of whether two strains should be considered the same, allowing to determine bacterial clearance and acquisition from genomes sampled over time. We explicitly model the within-host variation using population genetic simulation, and the inference is done by combining information from multiple data sources by using a combination of Approximate Bayesian Computation (ABC) and Markov Chain Monte Carlo (MCMC). We use the method to analyse a collection of methicillin resistant Staphylococcus aureus (MRSA) isolates.
△ Less
Submitted 27 November, 2018;
originally announced November 2018.
